P07477 (TRY1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 152.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Trypsin-1 EC=3.4.21.4 Alternative name(s): Beta-trypsin Cationic trypsinogen Serine protease 1 Trypsin I Cleaved into the following 2 chains: | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 247 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Has activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form against all of these substrates. Ref.9 |
| Catalytic activity | Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa. |
| Cofactor | Binds 1 calcium ion per subunit. |
| Subcellular location | |
| Post-translational modification | Occurs in a single-chain form and a two-chain form, produced by proteolytic cleavage after Arg-122. |
| Involvement in disease | Pancreatitis (PCTT) [MIM:167800]: A disease characterized by the presence of calculi in pancreatic ducts. It causes severe abdominal pain attacks. |
| Sequence similarities | Belongs to the peptidase S1 family. Contains 1 peptidase S1 domain. |
| Caution | Tyr-154 was proposed to be phosphorylated (Ref.15) but it has been shown (Ref.14) to be sulfated instead. Phosphate and sulfate groups are similar in mass and size, and this can lead to erroneous interpretation of the results. |
| Mass spectrometry | Molecular mass is 24348±2 Da from positions 24 - 247. Determined by ESI. Ref.15 |
Ontologies
| Keywords | |
|---|---|
| Biological process | Digestion |
| Cellular component | Secreted |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | Signal |
| Ligand | Calcium Metal-binding |
| Molecular function | Hydrolase Protease Serine protease |
| PTM | Disulfide bond Sulfation Zymogen |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | digestion Inferred from electronic annotation. Source: UniProtKB-KW extracellular matrix disassemblyTraceable author statement. Source: Reactome proteolysisInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | extracellular region Non-traceable author statement PubMed 14718574. Source: UniProtKB extracellular spaceInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | metal ion binding Inferred from electronic annotation. Source: UniProtKB-KW serine-type endopeptidase activityTraceable author statement Ref.11. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 15 | 15 | Ref.9 Ref.10 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 16 – 23 | 8 | Activation peptide | PRO_0000028197 | |||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 24 – 247 | 224 | Trypsin-1 | PRO_0000028198 | |||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 24 – 122 | 99 | Alpha-trypsin chain 1 | PRO_0000313570 | |||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 123 – 247 | 125 | Alpha-trypsin chain 2 | PRO_0000313571 | |||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 24 – 244 | 221 | Peptidase S1 | ||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 63 | 1 | Charge relay system | ||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 107 | 1 | Charge relay system | ||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 200 | 1 | Charge relay system | ||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 75 | 1 | Calcium | ||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 77 | 1 | Calcium; via carbonyl oxygen | ||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 80 | 1 | Calcium; via carbonyl oxygen | ||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 85 | 1 | Calcium | ||||||||||||||||||||||||||||||||||||||||||||||||
| Site | 194 | 1 | Required for specificity By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 154 | 1 | Sulfotyrosine Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 30 ↔ 160 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 48 ↔ 64 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 139 ↔ 206 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 171 ↔ 185 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 196 ↔ 220 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 16 | 1 | A → V in PCTT; disrupts signal sequence cleavage site. Ref.18 | VAR_011693 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 22 | 1 | D → G in PCTT; increased rate of activation. Ref.8 | VAR_011652 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 23 | 1 | K → R in PCTT; increased rate of activation. Ref.19 | VAR_011653 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 29 | 1 | N → I in PCTT. Ref.12 Ref.16 Ref.17 Ref.23 | VAR_006720 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 29 | 1 | N → T in PCTT. Ref.21 | VAR_012712 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 54 | 1 | N → S in PCTT; associated with Ile-29; the double mutant shows increased autocatalytic activation which is solely due to the Ile-29 mutation. Ref.23 | VAR_037908 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 79 | 1 | E → K in PCTT; Lys-79 trypsin activates anionic trypsinogen PRSS2 2-fold while the common pancreatitis-associated mutants His-122 or Ile-29 have no such effect. Ref.22 Corresponds to variant rs28934902 [ dbSNP | Ensembl ]. | VAR_037909 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 104 | 1 | L → P in PCTT. Ref.12 | VAR_011654 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 116 | 1 | R → C in PCTT. Ref.12 | VAR_011655 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 122 | 1 | R → C in PCTT; suppresses an autocleavage site. Ref.21 | VAR_012713 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 122 | 1 | R → H in PCTT; suppresses an autocleavage site which is probably part of a fail-safe mechanism by which trypsin, which is activated within the pancreas, may be inactivated; loss of this cleavage site would permit autodigestion resulting in pancreatitis. Ref.11 Ref.12 Ref.16 Ref.18 Ref.20 | VAR_006721 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 137 | 1 | T → M in a colorectal cancer sample; somatic mutation. Ref.24 | VAR_036299 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 139 | 1 | C → F in PCTT. Ref.12 | VAR_011656 | |||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 154 | 1 | Y → F: Lack of sulfation. Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 4 | 1 | L → F in AAI28227. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 38 – 54 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 57 – 60 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 62 – 64 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 70 – 74 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 76 – 80 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 86 – 95 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 101 – 103 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 109 – 115 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 120 – 122 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 138 – 144 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 149 – 151 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 159 – 165 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 168 – 174 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 176 – 178 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 183 – 187 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 192 – 194 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 203 – 206 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 209 – 216 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 218 – 222 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 227 – 231 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 232 – 235 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 236 – 245 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens." Emi M., Nakamura Y., Ogawa M., Yamamoto T., Nishide T., Mori T., Matsubara K. Gene 41:305-310(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The complete 685-kilobase DNA sequence of the human beta T cell receptor locus." Rowen L., Koop B.F., Hood L. Science 272:1755-1762(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Prostate. |
| [4] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [8] | "Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation." Teich N., Ockenga J., Hoffmeister A., Manns M., Mossner J., Keim V. Gastroenterology 119:461-465(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 15-67, VARIANT PCTT GLY-22. |
| [9] | "Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line." Koshikawa N., Yasumitsu H., Nagashima Y., Umeda M., Miyazaki K. Biochem. J. 303:187-190(1994) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 16-43 AND 123-142, FUNCTION, POST-TRANSLATIONAL PROCESSING. Tissue: Gastric adenocarcinoma. |
| [10] | "Immunoreactive anionic and cationic trypsin in human serum." Kimland M., Russick C., Marks W.H., Borgstroem A. Clin. Chim. Acta 184:31-46(1989) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 16-43. |
| [11] | "Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene." Whitcomb D.C., Gorry M.C., Preston R.A., Furey W., Sossenheimer M.J., Ulrich C.D., Martin S.P., Gates L.K. Jr., Amann S.T., Toskes P.P., Liddle R., McGrath K., Uomo G., Post J.C., Ehrlich G.D. Nat. Genet. 14:141-145(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 68-151, VARIANT PCTT HIS-122. |
| [12] | "Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants." Teich N., Bauer N., Mossner J., Keim V. Am. J. Gastroenterol. 97:341-346(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 68-151, VARIANTS PCTT ILE-29; PRO-104; CYS-116; HIS-122 AND PHE-139. |
| [13] | Lubec G., Afjehi-Sadat L. Submitted (MAR-2007) to UniProtKB Cited for: PROTEIN SEQUENCE OF 73-92, MASS SPECTROMETRY. Tissue: Brain and Cajal-Retzius cell. |
| [14] | "Human cationic trypsinogen is sulfated on Tyr154." Sahin-Toth M., Kukor Z., Nemoda Z. FEBS J. 273:5044-5050(2006) [PubMed] [Europe PMC] [Abstract] Cited for: SULFATION AT TYR-154, MUTAGENESIS OF TYR-154. |
| [15] | "Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151." Gaboriaud C., Serre L., Guy-Crotte O., Forest E., Fontecilla-Camps J.-C. J. Mol. Biol. 259:995-1010(1996) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS), MASS SPECTROMETRY. |
| [16] | "Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis." Gorry M.C., Gabbaizedeh D., Furey W., Gates L.K. Jr., Preston R.A., Aston C.E., Zhang Y., Ulrich C., Ehrlich G.D., Whitcomb D.C. Gastroenterology 113:1063-1068(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PCTT ILE-29 AND HIS-122. |
| [17] | "Mutations of the cationic trypsinogen in hereditary pancreatitis." Teich N., Mossner J., Keim V. Hum. Mutat. 12:39-43(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PCTT ILE-29. |
| [18] | "A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis." Witt H., Luck W., Becker M. Gastroenterology 117:7-10(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PCTT VAL-16 AND HIS-122. |
| [19] | "Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis." Ferec C., Raguenes O., Salomon R., Roche C., Bernard J.P., Guillot M., Quere I., Faure C., Mercier B., Audrezet M.-P., Guillausseau P.J., Dupont C., Munnich A., Bignon J.D., Le Bodic L. J. Med. Genet. 36:228-232(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PCTT ARG-23. |
| [20] | "A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis." Chen J.-M., Raguenes O., Ferec C., Deprez P.H., Verellen-Dumoulin C. J. Med. Genet. 37:E36-E36(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PCTT HIS-122. |
| [21] | "Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis." Pfutzer R., Myers E., Applebaum-Shapiro S., Finch R., Ellis I., Neoptolemos J., Kant J.A., Whitcomb D.C. Gut 50:271-272(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PCTT THR-29 AND CYS-122. |
| [22] | "Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2)." Teich N., Le Marechal C., Kukor Z., Caca K., Witzigmann H., Chen J.-M., Toth M., Moessner J., Keim V., Ferec C., Sahin-Toth M. Hum. Mutat. 23:22-31(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PCTT LYS-79, CHARACTERIZATION OF VARIANT PCTT LYS-79. |
| [23] | "Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl." Teich N., Nemoda Z., Koehler H., Heinritz W., Moessner J., Keim V., Sahin-Toth M. Hum. Mutat. 25:343-347(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PCTT ILE-29 AND SER-54, CHARACTERIZATION OF VARIANTS PCTT ILE-29 AND SER-54. |
| [24] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] MET-137. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M22612 mRNA. Translation: AAA61231.1. L36092 Genomic DNA. Translation: AAC80207.1. AK312199 mRNA. Translation: BAG35132.1. AC231380 Genomic DNA. No translation available. CH236959 Genomic DNA. Translation: EAL23773.1. CH471198 Genomic DNA. Translation: EAW51925.1. BC128226 mRNA. Translation: AAI28227.1. AF314534 Genomic DNA. Translation: AAG30943.1. U70137 Genomic DNA. Translation: AAC50728.1. AF315309 Genomic DNA. Translation: AAG30947.1. AF315310 Genomic DNA. Translation: AAG30948.1. AF315311 Genomic DNA. Translation: AAG30949.1. | ||||||||||||||||||||||||
| IPI | IPI00011694. | ||||||||||||||||||||||||
| PIR | A25852. S50020. S50021. | ||||||||||||||||||||||||
| RefSeq | NP_002760.1. NM_002769.4. | ||||||||||||||||||||||||
| UniGene | Hs.449281. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P07477. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | P07477. 3 interactions. | ||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||
| MEROPS | S01.127. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P07477. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 136408. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P07477. | ||||||||||||||||||||||||
| PeptideAtlas | P07477. | ||||||||||||||||||||||||
| PRIDE | P07477. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000311737; ENSP00000308720; ENSG00000204983. ENST00000561535; ENSP00000455361; ENSG00000261473. | ||||||||||||||||||||||||
| GeneID | 5644. | ||||||||||||||||||||||||
| KEGG | hsa:5644. | ||||||||||||||||||||||||
| UCSC | uc003wak.2. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 5644. | ||||||||||||||||||||||||
| GeneCards | GC07P142572. | ||||||||||||||||||||||||
| HGNC | HGNC:9475. PRSS1. | ||||||||||||||||||||||||
| HPA | CAB025487. CAB025538. | ||||||||||||||||||||||||
| MIM | 167800. phenotype. 276000. gene+phenotype. | ||||||||||||||||||||||||
| neXtProt | NX_P07477. | ||||||||||||||||||||||||
| Orphanet | 676. Hereditary chronic pancreatitis. | ||||||||||||||||||||||||
| PharmGKB | PA33828. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | COG5640. | ||||||||||||||||||||||||
| HOVERGEN | HBG013304. | ||||||||||||||||||||||||
| InParanoid | P07477. | ||||||||||||||||||||||||
| KO | K01312. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_118779. Extracellular matrix organization. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P07477. | ||||||||||||||||||||||||
| Bgee | P07477. | ||||||||||||||||||||||||
| Genevestigator | P07477. | ||||||||||||||||||||||||
| GermOnline | ENSG00000173636. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR001254. Peptidase_S1. IPR018114. Peptidase_S1_AS. IPR001314. Peptidase_S1A. IPR009003. Trypsin-like_Pept_dom. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00089. Trypsin. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00722. CHYMOTRYPSIN. | ||||||||||||||||||||||||
| SMART | SM00020. Tryp_SPc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF50494. Pept_Ser_Cys. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS50240. TRYPSIN_DOM. 1 hit. PS00134. TRYPSIN_HIS. 1 hit. PS00135. TRYPSIN_SER. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| BindingDB | P07477. | ||||||||||||||||||||||||
| ChEMBL | CHEMBL209. | ||||||||||||||||||||||||
| EvolutionaryTrace | P07477. | ||||||||||||||||||||||||
| GenomeRNAi | 5644. | ||||||||||||||||||||||||
| NextBio | 21926. | ||||||||||||||||||||||||
| PMAP-CutDB | P07477. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | TRY1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P07477 Secondary accession number(s): A1A509 Q9HAN7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
